Xi Zhang

Xi Zhang

Auto-generated profile, based on publicly available information

Xi Zhang

Department of Urology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, People’s Republic of China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Autoimmunity
Verified
Journal Article
Closed access
XDXiaojun Duan
Xiaojun Duan
XZXi Zhang
Xi Zhang
NDNiu Ding
Niu Ding
JZJi-Yan Zhang
Ji-Yan Zhang
YCYan-Ping Chen
Yan-Ping Chen
Asthma is a common respiratory disease which is characterized by persistent airway inflammation. Abnormal expression of long non-coding RNAs (lncRNAs) is observed in asthma. However, whether lncRNA nuclear-enriched abundant transcript 1 (NEAT1) regulates asthmatic inflammation and its mechanism still needs to be further investigated. The expression levels of inflammatory factors (tumour necrosis factor (TNF)-α, interleukin (IL)-4, IL-13, and IL-10) were detected using reverse transcription quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA). MTT and flow cytometry assays were employed to determine cell proliferation and apoptosis, respectively. Dual luciferase reporter assay was performed to verify the relationship between miR-200a/b and MMP-16 or NEAT1. NEAT1 silencing markedly reduced TNF-α, IL-4, and IL-13 levels, while elevated IL-10 expression, suppressed cell proliferation, and promoted cell apoptosis. However, NEAT1 overexpression elicited the opposite effects on cell proliferation and inflammation cytokines secretion. What is more, NEAT1 negatively regulated miR-200a/b expression, and MMP16 was a target gene of miR-200a/b. miR-200a/b overexpression suppressed inflammation, cell proliferation, and enhanced cell apoptosis through regulation of MMP16. Moreover, MMP-16 overexpression or miR-200a/b inhibition abolished the regulatory effect of sh-NEAT1 on cell inflammation and apoptosis in BEAS-2B cells. NEAT1 acted as the role of sponge for miR-200a/b to regulate MMP-16 expression, thereby promoting asthma progression, suggesting that NEAT1 might have great potential as therapeutic target for asthma.

26 May 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
CKChantal Kroone
Chantal Kroone
CTChris Tieken
Chris Tieken
BKBegüm Kocatürk
Begüm Kocatürk
MPMadelon Paauwe
Madelon Paauwe
EBErik J. Blok
Erik J. Blok
HVHenri Versteeg
Henri Versteeg
Cancer enhances the risk of venous thromboembolism, but a hypercoagulant microenvironment also promotes cancer progression. Although anticoagulants have been suggested as a potential anticancer treatment, clinical studies on the effect of such modalities on cancer progression have not yet been successful for unknown reasons. In normal physiology, complex formation between the subendothelial-expressed tissue factor (TF) and the blood-borne liver-derived factor VII (FVII) results in induction of the extrinsic coagulation cascade and intracellular signaling via protease-activated receptors (PARs). In cancer, TF is overexpressed and linked to poor prognosis. Here, we report that increased levels of FVII are also observed in breast cancer specimens and are associated with tumor progression and metastasis to the liver. In breast cancer cell lines, tumor-expressed FVII drives changes reminiscent of epithelial-to-mesenchymal transition (EMT), tumor cell invasion, and expression of the prometastatic genes, SNAI2 and SOX9. In vivo, tumor-expressed FVII enhanced tumor growth and liver metastasis. Surprisingly, liver-derived FVII appeared to inhibit metastasis. Finally, tumor-expressed FVII-induced prometastatic gene expression independent of TF but required a functional endothelial protein C receptor, whereas recombinant activated FVII acting via the canonical TF:PAR2 pathway inhibited prometastatic gene expression. Here, we propose that tumor-expressed FVII and liver-derived FVII have opposing effects on EMT and metastasis.

13 December 2021 in International Urology and Nephrology
Verified
Journal Article
Open access
PDF file
XAXiaojie Ang
Xiaojie Ang
YJYufeng Jiang
Yufeng Jiang
ZCZongqiang Cai
Zongqiang Cai
QZQi Zhou
Qi Zhou
MLMiao Li
Miao Li
XZXi Zhang
Xi Zhang
Purpose: This study aimed to combine plasma netrin-1 and clinical parameters to construct a diagnostic model for bladder pain syndrome/interstitial cystitis (BPS/IC). Methods: We analyzed the independent diagnostic value of netrin-1 and the correlation with clinical symptom scores of BPS/IC. Clinical parameters were selected using LASSO regression, and a multivariate logistic regression model based on netrin-1 was established, and then a nomogram of BPS/IC prevalence was constructed. The nomogram was evaluated using calibration curves, the C-index, and decision curve analysis (DCA). Finally, the model was validated using an internal validation method. Results: The area under the curve for the ability of netrin-1 to independently predict BPS/IC diagnosis was 0.858 (p < 0.001), with a sensitivity of 85% and specificity of 82%. The predicted nomogram included three variables: age, CD3 + /CD4 + T lymphocyte ratio, and netrin-1. The C-index of this nomogram was 0.882, and the predicted values were highly consistent with the actual results in the calibration curve. In addition, the internally validated C-index of 0.870 confirms the high reliability of the model. DCA results show that the net patient benefit of the netrin-1 combined with other clinical parameters was higher than that of the single netrin-1 model. Conclusion: Netrin-1 can be used as a diagnostic marker for BPS/IC and is associated with pain. The nomogram constructed by combining netrin-1 and clinical parameters was able to predict BPS/IC with great accuracy. In addition, Netrin-1 may also serve as a novel therapeutic target for BPS/IC.

1 January 2021 in All Life
Verified
Journal Article
Open access
XAXiaojie Ang
Xiaojie Ang
ZXZeKun Xu
ZeKun Xu
QZQi Zhou
Qi Zhou
ZZZhiyu Zhang
Zhiyu Zhang
LMLu Ma
Lu Ma
WCWeiguo Chen
Weiguo Chen
Background: Enhancer RNA (eRNA) is a non-coding RNA transcribed by enhancers and has a crucial role in controlling gene transcription. However, the potential functions of eRNA in prostate cancer (PCa) are still not fully understood. Methods: Clinical information and expression data of eRNAs and their target genes for PCa were downloaded from TCGA. Each eRNA in PCa samples was divided into high- and low-expression groups. The Kaplan–Meier method was used to identify the eRNAs significantly associated with the overall survival of PCa. Their correlations with age, prostate-specific antigen (PSA), and tumor stage were analyzed using Spearman coefficients. Finally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEEG) analyzes were used to predict the possible biological functions and pathways associated with eRNAs. Results: We identified 12 eRNAs associated with PCa survival, of which PARGP1 was the most clinically significant. It was associated with biochemical recurrence in PCa patients and was also a valuable complement to distinguish between PSA 0–4 ng/ml and 4–10 ng/ml. GO, and KEEG analysis showed that herpes simplex virus-1 infection was the most biologically significant enriched process. Conclusions: PARGP1 is associated with biochemical recurrence in prostate cancer and contributes to assessing the outcome.